- Home
- TLYS vs OTLK Comparison
TLYS vs OTLK Comparison
Compare TLYS & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLYS
- OTLK
- Stock Information
- Founded
- TLYS 1982
- OTLK 2010
- Country
- TLYS United States
- OTLK United States
- Employees
- TLYS N/A
- OTLK N/A
- Industry
- TLYS Clothing/Shoe/Accessory Stores
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TLYS Consumer Discretionary
- OTLK Health Care
- Exchange
- TLYS Nasdaq
- OTLK Nasdaq
- Market Cap
- TLYS 44.0M
- OTLK 42.8M
- IPO Year
- TLYS 2012
- OTLK 2016
- Fundamental
- Price
- TLYS $1.39
- OTLK $1.26
- Analyst Decision
- TLYS Hold
- OTLK Buy
- Analyst Count
- TLYS 2
- OTLK 5
- Target Price
- TLYS $2.25
- OTLK $5.25
- AVG Volume (30 Days)
- TLYS 79.0K
- OTLK 879.6K
- Earning Date
- TLYS 12-03-2025
- OTLK 12-26-2025
- Dividend Yield
- TLYS N/A
- OTLK N/A
- EPS Growth
- TLYS N/A
- OTLK N/A
- EPS
- TLYS N/A
- OTLK N/A
- Revenue
- TLYS $549,597,000.00
- OTLK $1,505,322.00
- Revenue This Year
- TLYS N/A
- OTLK N/A
- Revenue Next Year
- TLYS $1.18
- OTLK $342.80
- P/E Ratio
- TLYS N/A
- OTLK N/A
- Revenue Growth
- TLYS N/A
- OTLK N/A
- 52 Week Low
- TLYS $0.57
- OTLK $0.79
- 52 Week High
- TLYS $4.77
- OTLK $6.61
- Technical
- Relative Strength Index (RSI)
- TLYS 32.27
- OTLK 49.95
- Support Level
- TLYS $1.37
- OTLK $1.13
- Resistance Level
- TLYS $1.45
- OTLK $1.29
- Average True Range (ATR)
- TLYS 0.07
- OTLK 0.08
- MACD
- TLYS -0.01
- OTLK -0.01
- Stochastic Oscillator
- TLYS 2.63
- OTLK 46.55
About TLYS Tilly's Inc.
Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.